The Radiologists’ Role in Diagnosing Lung Toxicity from Anti-Cancer Drugs
![The Radiologists’ Role in Diagnosing Lung Toxicity from Anti-Cancer Drugs](https://www.rsna.org/-/media/images/rsna/education/upcoming-education-events/radiologist-role-diagnosing-lung-toxicity-anti-cancer-drugs/lung-toxicity-001.jpg?rev=d1ec481388a64afb9705eb02dc662ae7&la=en&h=412&w=733&hash=0958308077122A3D32D8FE9E683443D4)
Join leading experts to sharpen your skills in diagnosing and treating lung toxicity from anti-cancer drugs during this free, one-hour webinar. This webinar is for health care professionals (HCPs) only and is sponsored by AstraZeneca and Daiichi Sankyo.
Webinar details
Date & time: Sept. 12, 2024; noon–1 p.m. CT
Price: Free
Enhance your understanding of interstitial lung disease (ILD)/pneumonitis related to anti-cancer drugs during this free, one-hour webinar (for HCPs only) sponsored by AstraZeneca and Daiichi Sankyo. Leading experts will share best practices and valuable insight related to ILD/pneumonitis risk factors, early diagnosis, the radiologist’s role within multi-disciplinary teams, and the monitoring and management of potential toxicity.
Learning objectives
- Enhance your understanding of interstitial lung disease (ILD)/pneumonitis related to anti-cancer drugs
- Discuss best practices related to ILD/pneumonitis risk factors, early diagnosis, the radiologist’s role within multi-disciplinary teams, and the monitoring and management of potential toxicity.
Speakers
![Professor Julien Dinkel](https://www.rsna.org/-/media/images/rsna/education/upcoming-education-events/radiologist-role-diagnosing-lung-toxicity-anti-cancer-drugs/julien-dinkel-500x600.jpg?rev=c1eb7430161a46cdb0370ba1e114de20&la=en&h=240&w=200&hash=DC001E5C2DC9C3961FA4A7B71FDBEACA)
Professor Julien Dinkel
Radiologist at Ludwig Maximilian University Hospital
Germany
![Professor Nikolaus Kneidinger](https://www.rsna.org/-/media/images/rsna/education/upcoming-education-events/radiologist-role-diagnosing-lung-toxicity-anti-cancer-drugs/nikolaus-kneidinger-500x600.jpg?rev=8f2333b587214e56ac9ba26c7e304723&la=en&h=240&w=200&hash=D04F68E81C5071AA4BADAAE00F96A68E)
Professor Nikolaus Kneidinger
Pulmonologist at LMU Klinikumder Universität München
Germany
This webinar is for HCPs only and is sponsored by AstraZeneca and Daiichi Sankyo.
DoP: August 2024 I JBN: Z4-67431